Zeng‐Hong Wu

1.6k total citations · 1 hit paper
51 papers, 931 citations indexed

About

Zeng‐Hong Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Zeng‐Hong Wu has authored 51 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Zeng‐Hong Wu's work include RNA modifications and cancer (17 papers), Ferroptosis and cancer prognosis (16 papers) and Cancer-related molecular mechanisms research (15 papers). Zeng‐Hong Wu is often cited by papers focused on RNA modifications and cancer (17 papers), Ferroptosis and cancer prognosis (16 papers) and Cancer-related molecular mechanisms research (15 papers). Zeng‐Hong Wu collaborates with scholars based in China, United States and Japan. Zeng‐Hong Wu's co-authors include Yun Tang, Yang Dongliang, Youjing Zhang, Qing Cheng, Cheng Li, Huadong Li, Xun Niu, Rong Lin, Hong Yu and Jia Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Zeng‐Hong Wu

49 papers receiving 916 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021

2024 73 citations Zeng‐Hong Wu, Rong Lin et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zeng‐Hong Wu China	15	431	305	294	148	110	51	931
Zhaoxian Cai China	6	438 1.0×	327 1.1×	455 1.5×	126 0.9×	185 1.7×	9	983
Sipeng Shen China	17	388 0.9×	238 0.8×	315 1.1×	154 1.0×	66 0.6×	67	1.0k
Paul B. Comish United States	10	499 1.2×	307 1.0×	451 1.5×	105 0.7×	215 2.0×	19	1.1k
Aldo Pezzuto Italy	20	316 0.7×	234 0.8×	411 1.4×	301 2.0×	68 0.6×	53	1.0k
Yangkai Li China	16	388 0.9×	173 0.6×	178 0.6×	186 1.3×	91 0.8×	42	772
María Buxó Spain	15	286 0.7×	248 0.8×	185 0.6×	196 1.3×	41 0.4×	75	872
Hong Peng China	20	373 0.9×	94 0.3×	400 1.4×	147 1.0×	173 1.6×	59	1.2k
Aman Xu China	16	343 0.8×	235 0.8×	298 1.0×	229 1.5×	152 1.4×	35	985
Yongmei Cao China	15	437 1.0×	323 1.1×	340 1.2×	34 0.2×	80 0.7×	24	927
Sha Fu China	21	456 1.1×	263 0.9×	269 0.9×	372 2.5×	61 0.6×	78	1.2k

Countries citing papers authored by Zeng‐Hong Wu

Since Specialization

Citations

This map shows the geographic impact of Zeng‐Hong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng‐Hong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng‐Hong Wu more than expected).

Fields of papers citing papers by Zeng‐Hong Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng‐Hong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng‐Hong Wu. The network helps show where Zeng‐Hong Wu may publish in the future.

Co-authorship network of co-authors of Zeng‐Hong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng‐Hong Wu. A scholar is included among the top collaborators of Zeng‐Hong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng‐Hong Wu. Zeng‐Hong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Zeng‐Hong, et al.. (2024). The Global Burden of Disease Attributable to High Body Mass Index in 204 Countries and Territories from 1990 to 2021 with Projections to 2050: An Analysis of the Global Burden of Disease Study 2021. European Journal of Heart Failure. 27(2). 354–365. 5 indexed citations

Wu, Zeng‐Hong, et al.. (2024). A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. International Journal of Surgery. 110(4). 2178–2186. 8 indexed citations

Wu, Zeng‐Hong, et al.. (2024). Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021. Journal of Hematology & Oncology. 17(1). 119–119. 73 indexed citations breakdown →

Wu, Zeng‐Hong, et al.. (2023). The impact of surgery and survival prediction in patients with gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. International Journal of Surgery. 109(6). 1629–1638. 4 indexed citations

Wu, Zeng‐Hong, et al.. (2023). Trends in the incidence of cirrhosis in global from 1990 to 2019: A joinpoint and age‐period‐cohort analysis. Journal of Medical Virology. 95(6). e28858–e28858. 17 indexed citations

Wu, Zeng‐Hong, Gangping Li, Weijun Wang, et al.. (2023). Immune checkpoints signature-based risk stratification for prognosis of patients with gastric cancer. Cellular Signalling. 113. 110976–110976. 2 indexed citations

Wu, Zeng‐Hong, Bian Wu, Cheng Li, Youjing Zhang, & Tao Zhou. (2022). Pyroptosis-Related Signature and Tumor Microenvironment Infiltration Characterization in Head and Neck Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology. 10. 702224–702224. 5 indexed citations

Wu, Zeng‐Hong, Cheng Li, Youjing Zhang, & Rong Lin. (2022). Bioinformatics Study Revealed Significance of Exosome Transcriptome in Hepatocellular Carcinoma Diagnosis. Frontiers in Cell and Developmental Biology. 10. 813701–813701. 10 indexed citations

Wu, Zeng‐Hong, Meng Zhao, Hong Yu, & Huadong Li. (2021). The impact of particulate matter 2.5 on the risk of hepatocellular carcinoma: a meta-analysis. International Archives of Occupational and Environmental Health. 95(3). 677–683. 14 indexed citations

10.

Wu, Zeng‐Hong, Yang Dongliang, Liang Wang, & Jia Liu. (2021). Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in Immunology. 12. 793343–793343. 25 indexed citations

11.

Wu, Zeng‐Hong, Yun Tang, Hong Yu, & Huadong Li. (2021). The role of ferroptosis in breast cancer patients: a comprehensive analysis. Cell Death Discovery. 7(1). 93–93. 85 indexed citations

12.

Wu, Zeng‐Hong, Yun Tang, & Yue Zhou. (2021). Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer. Scientific Reports. 11(1). 4841–4841. 9 indexed citations

13.

Wu, Zeng‐Hong, et al.. (2021). Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma. BMC Gastroenterology. 21(1). 265–265. 2 indexed citations

14.

Tang, Yun, Cheng Li, Youjing Zhang, & Zeng‐Hong Wu. (2021). Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma. International Journal of Biological Sciences. 17(3). 702–711. 113 indexed citations

15.

Li, Cheng, et al.. (2020). Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Disease Markers. 2020. 1–13. 10 indexed citations

16.

Wu, Zeng‐Hong, et al.. (2020). Comprehensive Analysis of the Expression and Prognosis for GBPs in Head and neck squamous cell carcinoma. Scientific Reports. 10(1). 6085–6085. 20 indexed citations

17.

Wu, Zeng‐Hong, Yi Zhong, Tao Zhou, & Hongjun Xiao. (2020). miRNA biomarkers for predicting overall survival outcomes for head and neck squamous cell carcinoma. Genomics. 113(1). 135–141. 23 indexed citations

18.

Wu, Zeng‐Hong, Yun Tang, & Qing Cheng. (2020). Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetologica. 58(2). 139–144. 110 indexed citations

19.

Zhang, Jizhou, Zeng‐Hong Wu, & Qing Cheng. (2019). Screening and identification of key biomarkers in nasopharyngeal carcinoma. Medicine. 98(48). e17997–e17997. 17 indexed citations

20.

Wu, Zeng‐Hong, et al.. (2018). The relationship between obstructive sleep apnea hypopnea syndrome and gastroesophageal reflux disease: a meta-analysis. Sleep And Breathing. 23(2). 389–397. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact